| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Revenue | $849.0M | +4.7% |
| Cost of Revenue | $745.7M | +5.4% |
| Gross Profit | $103.3M | -0.1% |
| R&D Expense | $23.0M | +13.8% |
| SG&A Expense | $79.4M | +0.1% |
| Operating Income | -$7.6M | +29.9% |
| Pre-tax Income | -$18.1M | +41.9% |
| Income Tax | $2.8M | -76.8% |
| Net Income | -$20.8M |
| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.7M | +35.9% |
| Accounts Receivable | $86.6M | +29.8% |
| Inventory | $250.1M | +1.7% |
| Current Assets | $452.6M | +12.8% |
| Total Assets | $995.6M | +6.1% |
| Current Liabilities | $135.7M | +37.1% |
| Long-term Debt | $128.5M | -48.3% |
| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.9M | -51.6% |
| Capital Expenditures | $17.6M | +13.8% |
| Investing Cash Flow | -$17.6M | -13.8% |
| Financing Cash Flow | $18.5M | +138.0% |
| Free Cash Flow | $10.2M | -75.7% |
| +51.6% |
| EPS (Basic) | -$0.64 | +56.5% |
| EPS (Diluted) | -$0.64 | +56.5% |
| Total Liabilities |
| $297.2M |
| -20.5% |
| Stockholders' Equity | $698.3M | +23.7% |